Literature DB >> 6787

The effects of metoclopramide in modifying the response of isolated guinea-pig ileum to various agonists.

R W Bury, M L Mashford.   

Abstract

Metoclopramide has a dual effect on intestinal smooth muscle. Low concentrations of metoclopramide cause potentiation of the responses to substance P, acetylcholine, histamine and barium chloride on the guinea-pig ileum. Higher concentrations produce a depression of smooth muscle responses which is characteristic of the tertiary amine local anesthetics. Neural pathways are involved in the mechanism of potentiation, since the enhancement of the responses to the agonists is abolished by tetrodotoxin. Atropine partially antagonizes the potentiating effect of metoclopramide implying that activation of muscarinic receptors is a contributing factor, but this does not fully explain the potentiation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6787

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  4 in total

1.  Field stimulation-induced responses of circular smooth muscle from guinea-pig stomach. Characterisation of the receptor mechanisms involved.

Authors:  B Costall; R J Naylor; C C Tan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-06       Impact factor: 3.000

2.  The effects of metoclopramide on acetylcholine release and on smooth muscle response in the isolated guinea-pig ileum.

Authors:  H Kilbinger; R Kruel; I Pfeuffer-Friederich; I Wessler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

3.  Involvement of enteric neurones in the response of guinea-pig ileum preparations to metoclopramide.

Authors:  J Bou; A G Fernández; J M Jauregui; R Massingham
Journal:  Br J Pharmacol       Date:  1986-05       Impact factor: 8.739

Review 4.  A History of Drug Discovery for Treatment of Nausea and Vomiting and the Implications for Future Research.

Authors:  Gareth J Sanger; Paul L R Andrews
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.